The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Temsirolimus combined with etoposide and cyclophosphamide for relapsed/refractory acute lymphoblastic leukemia: Therapeutic advances in Childhood Leukemia Consortium (TACL 2014-001) trial.
 
Susan R. Rheingold
Employment - OptiNose (I)
Stock and Other Ownership Interests - OptiNose (I)
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Lewis B. Silverman
Consulting or Advisory Role - Adaptive Biotechnologies; Servier; Takeda
Research Funding - Baxalta/Shire (Inst); Servier (Inst)
 
James A. Whitlock
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Shire Human Genetic Therapies
Research Funding - Daiichi Sankyo; Novartis
 
Richard Sposto
No Relationships to Disclose
 
Eric S. Schafer
No Relationships to Disclose
 
Kirk R. Schultz
Honoraria - Shire
Consulting or Advisory Role - Juno Therapeutics; MesoScale Discovery
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Raymond J. Hutchinson
No Relationships to Disclose
 
Paul S. Gaynon
No Relationships to Disclose
 
Caroline Bateman
Research Funding - Merck Sharp & Dohme
 
Todd Michael Cooper
Employment - Juno/Celgene (I)
Stock and Other Ownership Interests - Juno/Celgene (I)
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst)
 
Maria Luisa Sulis
No Relationships to Disclose
 
Alan S. Wayne
Consulting or Advisory Role - Abbvie (Inst); SERVIER (Inst)
Research Funding - Kite, a Gilead company (Inst); Spectrum Pharmaceuticals (Inst)
 
Sarah K. Tasian
Consulting or Advisory Role - Aleta Biotherapeutics
Research Funding - Gilead Sciences; Incyte